Clinical Trial Update: A Study to Characterize the Pharmacokinetics of DA-8031 in Healthy Male Subjects [Phase 1]

View source ↗

Summary

A completed Phase 1 pharmacokinetics study of DA-8031 in healthy male volunteers to characterize its PK profile for premature ejaculation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ejaculation

Drugs mentioned

• DA-8031

Snippet

Sponsor: Dong-A Pharmaceutical Co., Ltd. | Conditions: Premature Ejaculatory Dysfunction | Phase 1 | Status: COMPLETED